23/06/2026
CosmoTrace and VisioTT have signed a Strategic Cooperation Memorandum at the GCC Regulatory Affairs Summit in Dubai, establishing a strategic collaboration to support pharmaceutical serialization, aggregation, and traceability initiatives.
By combining their respective strengths, both organizations aim to provide customers with a broader portfolio of solutions to meet evolving regulatory and operational requirements.
The collaboration will also explore joint customer engagements, technology integration opportunities, and industry initiatives to support the continued advancement of pharmaceutical traceability across the GCC.
Zeeshan Ahmed Founder & CEO of CosmoTrace, said:
"We are delighted to partner with VISIOTT TPS as we continue to strengthen the pharmaceutical traceability ecosystem. This collaboration brings together complementary capabilities, enabling us to offer customers a broader range of serialization, aggregation, and traceability solutions. Together, we look forward to helping pharmaceutical companies navigate evolving regulatory requirements with practical, scalable, and future-ready solutions."
Görkem Aydın, Chief Marketing Officer of Visiott TPS, said:
"We are pleased to establish this strategic cooperation with CosmoTrace. By combining VISIOTT TPS's expertise in serialization, aggregation, and packaging line solutions with CosmoTrace's strong capabilities in regulatory reporting and supply chain visibility, we aim to deliver greater value to pharmaceutical manufacturers across the GCC region and beyond. Together, we look forward to supporting the industry's digital transformation and helping companies achieve compliance with evolving traceability requirements."
Representatives from both companies expressed their commitment to working together to support pharmaceutical manufacturers with practical, scalable, and compliant traceability solutions while contributing to the advancement of patient safety, supply chain transparency, and regulatory efficiency.
